Diabetes Notes

Drug from Takeda approved by FDA

by Maruthi on August 30th, 2005

ACTOS® (pioglitazone) and metformin are two widely used diabetes medications.  These medications help diabetics manage their plasma glucose levels.  A drug called Actoplus Met combines these two medications into a single tablet.  This drug has been developed by the U.S  Research and Development unit of Takeda Pharmaceutical company limited of Japan and has been approved by the U.S Food and Drug Administration (FDA) for the treatment of type 2 diabetes.  The drug will be launched in the U.S in october.   

You can read the press release here.

Share This

Related Stories

FDA approves sale of inhalable insulin
Diabetes inhaler recommended by FDA advisory panel
Actos helps in reducing heart risks
Smoking and Inhaled Insulin
Inhalable insulin for diabetics

POSTED IN: Uncategorized